poisar

Stocks · News reference

Genprex to Present Insights on Diabetes Gene Therapy Development at Future of Cell and Gene Therapy Symposium

Fiscal.ai

Genprex announced that Dr. Pier-Anne Lachance will present on the company's dual-delivery approach for diabetes gene therapy at the upcoming Future of Cell and Gene Therapy Symposium.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. SEC EDGARSEC EDGAR

    8-K filing — Genprex, Inc. (GNPX)

    Filed: 2026-11-04 AccNo: 0001437749-26-034764 Size: 172 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits